Working Groups
Artificial Intelligence
Developing responsible AI endpoints, data methods, and evaluation standards for NF clinical trials.
Leadership
About This Group
The Artificial Intelligence working group develops standards for using AI in NF clinical trials, including AI-assisted endpoints, imaging and data workflows, and responsible methodology for outcome measurement and trial design.
Current group leader: Frank Buono
Current Work
Newly formed group exploring AI-driven endpoints and methods for NF1, NF2-related schwannomatosis, and schwannomatosis clinical trials.
Additional Information
No additional sections yet.
Working Group Snapshot & Focus Updates
No snapshot update posted yet.
Publications & References
No publications listed yet.
Documents & Resources
No documents uploaded yet.
Join or Contact This Group
Membership is open to all interested parties. Meetings are primarily held by teleconference.
Express Interest